Author

Nadiia Lypova

University of LouisvilleORCID 0000-0003-1506-8545Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Brian F. ClemiD· 1 shared Jason Alan ChesneyiD· 1 shared Jing Chun FengiD· 1 shared Susan M. Dougherty· 1 shared Xiang ZhangiD· 1 shared Xiaohong LiiD· 1 shared Xinmin YiniD· 1 shared Yoannis Imbert-FernandeziD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brian F. ClemORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer & MetabolismPeer-reviewedDec 18, 2024

Role of 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 in Maintaining Redox Homeostasis and DNA Repair in Non-Small Cell Lung Cancers Under EGFR-Targeting Therapy

Nadiia Lypova, Susan M. Dougherty, Brian F. Clem…·Yoannis Imbert-Fernandez

This study shows that inhibiting PFKFB3 enhances the effectiveness of EGFR-TKIs by disrupting metabolic adaptations and DNA repair in drug-tolerant lung cancer cells.

12 citations

humanproteomics

𝕏 PostBluesky